People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker announced Thursday...
.png)
Copyright © 2023 ainews.market-touch.org. All Rights Reserved
